BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26911281)

  • 1. Iron induces cancer stem cells and aggressive phenotypes in human lung cancer cells.
    Chanvorachote P; Luanpitpong S
    Am J Physiol Cell Physiol; 2016 May; 310(9):C728-39. PubMed ID: 26911281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells.
    Yongsanguanchai N; Pongrakhananon V; Mutirangura A; Rojanasakul Y; Chanvorachote P
    Am J Physiol Cell Physiol; 2015 Jan; 308(2):C89-100. PubMed ID: 25411331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
    Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
    Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
    Phiboonchaiyanan PP; Chanvorachote P
    Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lusianthridin targeting of lung cancer stem cells via Src-STAT3 suppression.
    Bhummaphan N; Petpiroon N; Prakhongcheep O; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 Sep; 62():152932. PubMed ID: 31100681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Stem Cell-Suppressing Activity of Chrysotoxine, a Bibenzyl from
    Bhummaphan N; Pongrakhananon V; Sritularak B; Chanvorachote P
    J Pharmacol Exp Ther; 2018 Feb; 364(2):332-346. PubMed ID: 29217540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma.
    Luanpitpong S; Li J; Manke A; Brundage K; Ellis E; McLaughlin SL; Angsutararux P; Chanthra N; Voronkova M; Chen YC; Wang L; Chanvorachote P; Pei M; Issaragrisil S; Rojanasakul Y
    Oncogene; 2016 Jun; 35(22):2824-33. PubMed ID: 26387547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SOX9-Aldehyde Dehydrogenase Axis Determines Resistance to Chemotherapy in Non-Small-Cell Lung Cancer.
    Voronkova MA; Rojanasakul LW; Kiratipaiboon C; Rojanasakul Y
    Mol Cell Biol; 2020 Jan; 40(2):. PubMed ID: 31658996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
    Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
    PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype.
    Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J
    J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX9 Regulates Cancer Stem-Like Properties and Metastatic Potential of Single-Walled Carbon Nanotube-Exposed Cells.
    Voronkova MA; Luanpitpong S; Rojanasakul LW; Castranova V; Dinu CZ; Riedel H; Rojanasakul Y
    Sci Rep; 2017 Sep; 7(1):11653. PubMed ID: 28912540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
    Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
    Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEAT1 acts as an inducer of cancer stem cell-like phenotypes in NSCLC by inhibiting EGCG-upregulated CTR1.
    Jiang P; Chen A; Wu X; Zhou M; Ul Haq I; Mariyam Z; Feng Q
    J Cell Physiol; 2018 Jun; 233(6):4852-4863. PubMed ID: 29152741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
    Kawai T; Yasuchika K; Ishii T; Miyauchi Y; Kojima H; Yamaoka R; Katayama H; Yoshitoshi EY; Ogiso S; Kita S; Yasuda K; Fukumitsu K; Komori J; Hatano E; Kawaguchi Y; Uemoto S
    Sci Rep; 2016 Jul; 6():30489. PubMed ID: 27457505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMPRSS4 induces cancer stem cell-like properties in lung cancer cells and correlates with ALDH expression in NSCLC patients.
    de Aberasturi AL; Redrado M; Villalba M; Larzabal L; Pajares MJ; Garcia J; Evans SR; Garcia-Ros D; Bodegas ME; Lopez L; Montuenga L; Calvo A
    Cancer Lett; 2016 Jan; 370(2):165-76. PubMed ID: 26546046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HSPA1L Enhances Cancer Stem Cell-Like Properties by Activating IGF1Rβ and Regulating β-Catenin Transcription.
    Choi SI; Lee JH; Kim RK; Jung U; Kahm YJ; Cho EW; Kim IG
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32971893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.
    Song S; Ajani JA; Honjo S; Maru DM; Chen Q; Scott AW; Heallen TR; Xiao L; Hofstetter WL; Weston B; Lee JH; Wadhwa R; Sudo K; Stroehlein JR; Martin JF; Hung MC; Johnson RL
    Cancer Res; 2014 Aug; 74(15):4170-82. PubMed ID: 24906622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ti
    Petpiroon N; Bhummaphan N; Soonnarong R; Chantarawong W; Maluangnont T; Pongrakhananon V; Chanvorachote P
    Mol Pharmacol; 2019 Apr; 95(4):418-432. PubMed ID: 30737252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.